Paul Biondi, Pioneering Medicines president
July 18, 2023 07:00 AM EDT
Deals
Bioregnum

Pfiz­er, Flag­ship al­ly on a $100M cash launch of a drug dis­cov­ery ex­pe­di­tion

Paul Bion­di has hatched a new de­vel­op­ment deal at Flag­ship Pi­o­neer­ing, and this one comes wrapped with a $100 mil­lion cash bow ar­riv­ing on the …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times